Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANTHARTIC: Antibiotic Prophylaxis for VAP in Cardiac Arrest
NCT02186951Phase 3Completed
- Sponsor
- CHU de Limoges
- Start
- Aug 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amoxicillin + clavulanate in ventilator-associated pneumonia (VAP), sponsored by CHU de Limoges. Started Aug 2014; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT02186951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02186951.